Clinical Trial Update: Clinical Study of Trop2 CAR-NK in the Treatment of Relapsed/Refractory Non-Small Cell Lung Cancer (NSCLC) [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating Trop2 CAR-NK therapy for relapsed/refractory non-small cell lung cancer, currently not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Trop2 CAR-NK

Snippet

Sponsor: Henan Cancer Hospital | Conditions: Non-Small Cell Lung Cancer NSCLC | Phase 1, Phase 2 | Status: NOT_YET_RECRUITING